Delivery Order SPE2DB22D2006-SPE2DB25FW3BK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,357.62 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, an ergot alkaloid medication used primarily in obstetric settings. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg tablets (28-count packages) with a ceiling value of $3,229.90. The contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025. Performance will take place at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $1,555.82 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- The Defense Logistics Agency awarded a $574 delivery order to Amerisourcebergen Drug Corporation for the supply of 12 tablets of 0.2 mg methylergonovine, used to treat postpartum hemorrhage. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to a customer located in Conshohocken, Pennsylvania by August 7, 2023 under a firm fixed price contract. No major subcontractors or set aside designations were identified. This order is consistent with DLA's mission to provide medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.24 firm fixed-price contract is for the supply of methylergonovine 0.2 mg/ml ampompoules, a prescription medication. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,661.21 firm fixed-price delivery order is for the supply of methylergonovine 0.2 mg/ml, a medication used to treat postpartum hemorrhage. The contract has a completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of methylergonovine 0.2 mg/ml vials, a medication used to treat postpartum hemorrhage. The contract has a ceiling value of $1,261.51 and runs through March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylergonovine 0.2 mg/ml injections. The contract has a total ceiling value of $1,794.96 and is a firm fixed-price delivery order. It does not have a set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3BKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The performance location for this order is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies critical pharmaceutical products and medical commodities to federal healthcare systems through its relationship with the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive experience fulfilling military medical procurement requirements on a competitive basis. Methylergonovine, an ergot alkaloid used in obstetric care for managing postpartum hemorrhage, represents a specialized pharmaceutical product consistent with AmerisourceBergen's role as a primary vendor for military and veteran healthcare supply chains. This delivery order exemplifies the routine pharmaceutical procurement activities executed under the broader SPE2DX global pharmaceutical support vehicle, which enables AmerisourceBergen to supply diverse medical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/3/25 |